
GeneDx Investors Face August Deadline in Securities Fraud Lawsuit
Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, have until August 3, 2026, to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the integration and viability of the Fabric acquisition.
























